KEGG   DRUG: Pacmilimab
Entry
D11948                      Drug                                   
Name
Pacmilimab (USAN/INN)
Formula
C6718H10374N1810O2144S48
Exact mass
152244.4972
Mol weight
152338.2128
Sequence
(Heavy chain)
EVQLLESGGG LVQPGGSLRL SCAASGFTFS SYAMSWVRQA PGKGLEWVSS IWRNGIVTVY
ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCAKWS AAFDYWGQGT LVTVSSASTK
GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEF LGGPSVFLFP
PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE QFNSTYRVVS
VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS QEEMTKNQVS
LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK SRWQEGNVFS
CSVMHEALHN HYTQKSLSLS LG
(Light chain)
QGQSGSGIAL CPSHFCQLPQ TGGGSSGGSG GSGGISSGLL SGRSDNHGGS DIQMTQSPSS
LSASVGDRVT ITCRASQSIS SYLNWYQQKP GKAPKLLIYA ASSLQSGVPS RFSGSGSGTD
FTLTISSLQP EDFATYYCQQ DNGYPSTFGG GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA
SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK
VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H130-L264, H143-H199, H222-H'222, H225-H'225, H257-H317, H363-H421, H'22-H'96, H'130-L'264, H'143-H'199, H'257-H'317, H'363-H'421, L11-L16, L73-L138, L184-L244, L'11-L'16, L'73-L'138, L'184-L'244)
  Type
Peptide
Class
Antineoplastic
 DG02938  Immune checkpoint inhibitor
Efficacy
Antineoplastic, Anti-PD-1 antibody
  Type
Monoclonal antibody
Comment
Treatment of cancer
Target
PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]
  Pathway
hsa04514  Cell adhesion molecules
hsa04660  T cell receptor signaling pathway
hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG02938  Immune checkpoint inhibitor
   D11948  Pacmilimab
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   Immune checkpoints
    PDCD1 (PD1, CD279)
     D11948  Pacmilimab (USAN/INN)
Other DBs
CAS: 2145091-51-4
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system